Back
Home » Health
  •  
    Filmi Bollywood
    • Ranveer Singh, Alia Bhatt Are ECSTATIC About Gully Boy’s Oscar Entry; 'Making A Mark On World Stage'
    • Vicky Kaushal Compares Playing His Sardar Udham Singh Character To His Takht Character
    • Karan Johar Reveals He Cried When Article 377 Was Abolished, Says Next Is Same-s*x Marriages
    • Tiger Shroff Approached For 'Khalnayak' Sequel; Sanjay Dutt Confirms & Reveals Details!
    • Kiara Advani On Being A Part Of Bhool Bhulaiyaa 2: I Am A Huge Fan Of 'Bhool Bhulaiyaa'
    • Happy Birthday Kareena Kapoor Khan: Actress Shares A Kiss With Saif To Begin The Celebrations!
    • Rahul Bose Pledges To Donate Organs: 'I'll Pledge Every Square Inch Of My Body'
    • CONTROVERSIAL: Urvashi Rautela Breaks Silence On Her ‘INAPPROPRIATE VIDEO’ With Boney Kapoor
    • Sonam Kapoor Opens Up On Suffering From Skin & Body Insecurities When She Was Younger
    • Yami Gautam To Devote Time For Organic Farming After ‘Ginny Weds Sunny’ Wraps!
    • Gaadi Mein Aana Hai Humare Saath? Obsessive Paparazzi Bowled Over By Janhvi Kapoor
    • Pal Pal Dil Ke Paas Movie Review: Karan Deol's Film Struggles To Stay Close To The Heart!
    • Isha Sharvani Duped Of Rs 3 Lakh By Fake Call Centre Employees; 3 Held
    • Karisma Kapoor, Sunny Deol Face Charges For Pulling Chain In Train During Shooting
Study Reveals A New Drug May Help Treat Brain Tumours
Boldsky | 12th Aug, 2019 03:23 PM

The research team led by Dr Richard Hill at the Brain Tumour Research Centre at University of Portsmouth (in collaboration with the University of Algarve (Portugal), the University of Liverpool (UK) and Innovate Pharmaceuticals) examined the possible impact of IP1867B in treating a brain tumour, which kills thousands of people every year.

IP1867B, the potential brain cancer treatment drug may help in shrinking brain tumours. The research study was conducted by applying the drug to existing (cancer) treatments and IP1867B was effective in boosting the potency of the treatments and renewed sensitivity to some treatments.

Also read: Artificial Intelligence Can Help Decode Epileptic Brains, Affirms Research

IP1867B can be termed as a revolutionary finding considering the limited success rates of cancer treatments. The limitation of the treatments is due to several factors such as the tumour's ability to develop resistance and hide from the treatment, lack of clinical effectiveness of the treatment, severe side effects and the inability of the medicine to penetrate through the blood-brain barrier. Consequently, during the study, IP1867B was successful at bypassing such factors .

In the study, 'IP1867B suppresses the insulin-like growth factor 1 receptor (IGF1R)...adult high-grade gliomas' published in the journal of Cancer Letters suggested that IP1867B - a combination of aspirin, triacetin and saccharin, worked towards reducing the size of adult high-grade glioma brain tumours in a mouse model. Along with that, the drug also helped in reducing the gastrointestinal tract problems caused due to the consumption of conventional aspirin tablets.

Therefore, the researchers asserted that IP1867B could be effective against one of the most aggressive forms of human brain cancer, glioblastoma (GBM). According to Dr Hill, the researcher team head, "To produce a completely new drug takes many years and is very expensive. By focusing our efforts on testing novel formulation techniques, we can move closer to treatment more quickly than would otherwise be possible."

He continued, "We will continue to urgently investigate which drugs will combine most effectively and safely with IP1867B, to improve these results even further and reduce the need for long-term use. There is still much work to be done, but many reasons to be excited about future studies."

The researcher tested various combinations of drugs to understand the most effective treatment, which also included separately testing the three key components of IP1867B. It was found that IP1867B was more effective than some of the chemotherapeutics being used in treatments.

The drug, IP1867B reduced the action of Epidermal Growth Factor Receptor (EGFR) and blocked the Insulin-like Growth Factor 1 pathway. This, in turn, helped reduce the tumour's ability to acquire resistance to the EGFR inhibitors. IP1867B can affect multiple targets, which in turn helps in highlighting the tumour and reverse acquired resistance .

Also read: Medication To Suppress HIV Infection Discovered, Researchers Assert

Dr James Stuart, Medical Director at Innovate Pharmaceuticals asserted, "The next step is to take IP1867B into 'first in human' trial. Innovate are actively driving this next stage of development."

   
 
Health and Life
  • 12 Amazing Health Benefits Of Mangosteen
  • Paranoid Personality Disorder (PPD): Causes, Symptoms, Diagnosis And Treatment
  • Skin Abscess: Causes, Symptoms, Diagnosis, Prevention And Treatment
    • How Does Your Oral Health Affect Your Overall Health?
    • 17 Tick-borne Diseases You Should Be Aware Of
    • 10 Nutritional Health Benefits Of Loquat
      • Chemicals In Beauty Products May Harm Women's Reproductive Hormones, Says Study
      • How To Brush Your Teeth Correctly
      • Celiac Disease: Symptoms, Causes, Risk Factors, Diagnosis And Treatment
        • Primary Amoebic Meningoencephalitis: Causes, Symptoms, Diagnosis, Treatment And Prevention
        • 19 Amazing Health Benefits Of Hops
        • Does Eating Too Much Sugar Cause Diabetes?
          • World Ozone Day 2019: Products That Cause Ozone Depletion And Their Eco-friendly Alternatives
          • Sebaceous Horn (Devil’s Horn): Causes, Symptoms, Risk Factors, Treatment, And Prevention
          • 10 Benefits Of Cycling For Your Health
            • Microcytic Anemia: Symptoms, Causes, Risk Factors, Treatment, And Prevention
            • Cyberchondria: How The Internet Can Affect Your Mental Health
            • Everything You Need To Know About The Hypercholesterolemia (High Cholesterol Levels) Condition
              • Fournier Gangrene: Causes, Symptoms, Risk factors, Treatment, And Prevention
              • Milk And Yoghurt May Help Improve Your Heart Health
              • World Sepsis Day 2019: Sepsis In Infants And Children